Statins
Dec 17, 2021
Mode of action inhibit HMG-CoA reductase in the liver, leading to decreased cholesterol synthesis
S/E myopathy, liver impairment
C/I macrolides, pregnancy/breastfeeding, ALT>3x
Monitoring
- TFTs, U&Es, LFTs before starting; LFTs also at 3m, 12m, then yearly.
- CK pre-Rx if muscle aches and pains
- HbA1c pre- and 3m if high risk of DM
- Lipids — baseline and then at 3m. Aim 40% drop in non-HDL cholesterol
Dosing
Primary Prevention atorvastatin 20mg OD
Secondary Prevention atorvastatin 80mg OD